A new trading day began on Tuesday, with Pacific Biosciences of California Inc (NASDAQ: PACB) stock price down -7.89% from the previous day of trading, before settling in for the closing price of $1.52. PACB’s price has ranged from $0.85 to $2.72 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -23.55%. Meanwhile, its annual earnings per share averaged -67.14%. With a float of $264.44 million, this company’s outstanding shares have now reached $300.35 million.
Pacific Biosciences of California Inc (PACB) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Pacific Biosciences of California Inc is 11.96%, while institutional ownership is 56.88%. The most recent insider transaction that took place on Aug 18 ’25, was worth 35,182. In this transaction an insider of this company sold 26,836 shares at a rate of $1.31, taking the stock ownership to the 1,920,035 shares. Before that another transaction happened on Aug 18 ’25, when Company’s Officer proposed sale 26,836 for $1.31, making the entire transaction worth $35,174.
Pacific Biosciences of California Inc (PACB) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.17 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -67.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.13% during the next five years compared to -23.55% drop over the previous five years of trading.
Pacific Biosciences of California Inc (NASDAQ: PACB) Trading Performance Indicators
Here are Pacific Biosciences of California Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.27, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of Pacific Biosciences of California Inc (PACB)
The latest stats from [Pacific Biosciences of California Inc, PACB] show that its last 5-days average volume of 6.6 million was inferior to 9.13 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 78.06%.
During the past 100 days, Pacific Biosciences of California Inc’s (PACB) raw stochastic average was set at 60.44%, which indicates a significant increase from 56.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0801 in the past 14 days, which was lower than the 0.1000 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3092, while its 200-day Moving Average is $1.3728. Now, the first resistance to watch is $1.4900. This is followed by the second major resistance level at $1.5800. The third major resistance level sits at $1.6300. If the price goes on to break the first support level at $1.3500, it is likely to go to the next support level at $1.3000. Assuming the price breaks the second support level, the third support level stands at $1.2100.
Pacific Biosciences of California Inc (NASDAQ: PACB) Key Stats
With a market capitalization of 420.52 million, the company has a total of 300,371K Shares Outstanding. Currently, annual sales are 154,010 K while annual income is -309,850 K. The company’s previous quarter sales were 39,770 K while its latest quarter income was -41,930 K.
